placebo (95%CI：9.27~74.62). In the higher dose group, 41.7% of patients (5/12) achieved a validated Investigator's Global Assessment for Atopic Dermatitis (vIGA-AD™) score of 0 (clear) or 1 (almost ...

Upadacitinib outperformed dupilumab for clinically meaningful pruritus improvement among patients with moderate to severe atopic dermatitis as early as day 2 of treatment. As pruritus is the chief ...

A study found that children with early-onset atopic dermatitis have a higher risk of developing uveitis and should be closely monitored for its onset. Taiwanese investigators found in their cohort ...

Children with early-onset atopic dermatitis (AD) were nearly twice as likely to develop pediatric uveitis as were those without the condition. The elevated risk was independent of a history of ...

Just because dry skin itches does not automatically make the diagnosis of atopic dermatitis—psoriasis and lichen planus can both be itchy and appear dry but have different pathways of inflammation in ...

Atopic dermatitis is the most common type of eczema, and it's primarily diagnosed by a visual examination and collecting your health history. There are no laboratory tests that can confirm an atopic ...

The current treatment options for atopic dermatitis range from being basic, fundamental skincare, gentle skincare, we refer to it. That means really avoiding some of those allergens, like ...

Atopic dermatitis (AD) highlights from the 2025 American Academy of Dermatology Annual Meeting include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream ...